#VisualAbstract: Local therapy is effective for the treatment of solitary melanoma progression

byTeddy Guo

July 28, 2021

in StudyGraphics

Reading Time: 1 min read

Study identifies distinct hemoglobin A1c patterns in adolescents over time

RelatedReports

Pimecrolimus effective first-line treatment for atopic dermatitis

Chronic Disease

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

March 29, 2023

StudyGraphics

#VisualAbstract: Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

March 24, 2023

Hidradenitis suppurativa associated with increased risk of subclinical atherosclerosis

Chronic Disease

Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

March 16, 2023

StudyGraphics

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

March 15, 2023

Pre-operative transcranial magnetic stimulation useful for language mapping

Carboplatin during radiotherapy recommended exclusively in pediatric patients with high-risk group 3 medulloblastoma

#VisualAbstract: Inequities in aortic stenosis and aortic valve replacement between Black/African American, White, and Hispanic patients

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Analysis of the short and long-term in-hospital complications following diagnosis of COVID-19

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Local therapy is effective for the treatment of solitary melanoma progression

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

#VisualAbstract: Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

Study identifies distinct hemoglobin A1c patterns in adolescents over time

Carboplatin during radiotherapy recommended exclusively in pediatric patients with high-risk group 3 medulloblastoma

RelatedReports

Lebrikizumab effective in treating moderate-to-severe atopic dermatitis

#VisualAbstract: Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

Carboplatin during radiotherapy recommended exclusively in pediatric patients with high-risk group 3 medulloblastoma

#VisualAbstract: Inequities in aortic stenosis and aortic valve replacement between Black/African American, White, and Hispanic patients

Analysis of the short and long-term in-hospital complications following diagnosis of COVID-19

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Local therapy is effective for the treatment of solitary melanoma progression

RELATED REPORTS

Study identifies distinct hemoglobin A1c patterns in adolescents over time

Carboplatin during radiotherapy recommended exclusively in pediatric patients with high-risk group 3 medulloblastoma

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?